RUNX2 and acute myeloid leukemia: We have further confirmed this novel link between NLRP3 and eIF2 signaling in additional AML cell lines, including OCI-AML3, MV4-11, THP-1 and MOLM-13, as we show that inhibition of NLRP3 leads to increased eIF2α phosphorylation.